Sort
39,280 grants matching “leukemia”
A chicken model to study hepatitis E virus pathogenesis
$394,859Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2014 · AI
Role of Gab2 and Shp2 in Hematopoietic Signalling
$394,842Benjamin G. Neel · Beth Israel Deaconess Medical Center · R01 · FY2006 · CA
Validating the eCyPA/CD147 signaling complex for myeloma therapy
$394,823Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Validating the eCyPA/CD147 signaling complex for myeloma therapy
$394,823Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2016 · CA
T-Cell Targeting for GVHD
$394,812Bruce R. Blazar · University Of Minnesota · R01 · FY2015 · HL
Pediatric Preclinical Testing Consortium - Leukemia
$394,802Richard B Lock · University Of New South Wales · U01 · FY2018 · CA
Polycomb genes and keratinocyte function
$394,799Richard L Eckert · University Of Maryland Baltimore · R01 · FY2010 · AR
DOXORUBICIN CARDIOMYOPATHY: MOLECULAR GENETICS &RESCUE
$394,780University Of Southern California · R01 · FY2000 · HL
Identification of stromal responses during castration-induced thymic regrowth.
$394,738Howard T. Petrie · Scripps Research Institute, The · R01 · FY2010 · AG
Directing AML therapy with BH3 profiling
$394,614Anthony G Letai · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Targeted aberrant signaling in CBL-mutant leukemia
$394,614Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Define the role of POT1 mutations in genome instability and cancer
$394,567Agnel Sfeir · New York University School Of Medicine · U01 · FY2019 · CA
Immunogenetics of Outcomes Disparities after Allogeneic HCT
$394,548Effie W Petersdorf · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Role of Forkhead Proteins in Insulin Action
$394,542Domenico Accili · Columbia University Health Sciences · R01 · FY2007 · DK
Repression via Facultative Heterochromatin
$394,511Danny F Reinberg · New York University School Of Medicine · R01 · FY2022 · CA
Understanding the niche of minimal residual disease leukemia cells
$394,511Yong-Mi Kim · Children'S Hospital Of Los Angeles · R01 · FY2022 · CA
Regulation of B Cell Development and Function by Zfp521
$394,505James R Hagman · National Jewish Health · R01 · FY2015 · AI
PATHOGENESIS OF NOTCH 1 LEUKEMIA
$394,502Brigham And Women'S Hospital · R01 · FY2001 · CA
Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores
$394,463Kyung W Lee · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Regulation of B Cell Development and Function by Zfp521
$394,444James R Hagman · National Jewish Health · R01 · FY2016 · AI
Development of a Production Method for Scaling Up Lentiviral Vector Manufacture
$394,406Madhusudan Viswanath Peshwa · Maxcyte, Inc. · R44 · FY2009 · HL
Role of Gab2 and Shp2 in Hematopoietic Signalling
$394,394Benjamin G. Neel · Beth Israel Deaconess Medical Center · R01 · FY2007 · CA
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
$394,389Matthew H Porteus · Stanford University · R01 · FY2017 · AI
The Contribution ofInfection to Preleukemic Clonal Hematopoiesis
$394,357Katherine Yudeh King · Baylor College Of Medicine · R01 · FY2019 · HL
Long-Term Follow-up Core
$394,331Paul J Martin · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA